Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Revenue (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Revenue for 8 consecutive years, with $34.2 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 5261.13% to $34.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $34.3 million through Dec 2025, down 50.12% year-over-year, with the annual reading at $34.3 million for FY2025, 50.12% down from the prior year.
  • Revenue for Q4 2025 was $34.2 million at Precision Biosciences, up from $13000.0 in the prior quarter.
  • The five-year high for Revenue was $68.8 million in Q2 2021, with the low at $13000.0 in Q3 2025.
  • Average Revenue over 5 years is $14.6 million, with a median of $8.1 million recorded in 2022.
  • The sharpest move saw Revenue soared 6282.65% in 2021, then plummeted 99.96% in 2025.
  • Over 5 years, Revenue stood at $6.3 million in 2021, then surged by 67.19% to $10.6 million in 2022, then crashed by 33.59% to $7.0 million in 2023, then crashed by 90.93% to $638000.0 in 2024, then surged by 5261.13% to $34.2 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $34.2 million, $13000.0, and $18000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.